Revenue Insights: Amgen Inc. and Bio-Techne Corporation Performance Compared

Revenue Growth: Amgen Inc. vs. Bio-Techne Corporation

In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Amgen Inc. and Bio-Techne Corporation have demonstrated contrasting trajectories. From 2014 to 2023, Amgen Inc. has seen a steady increase in revenue, growing approximately 40% from 2014 to 2023. In 2023, Amgen's revenue peaked at nearly $28 billion, showcasing its robust market presence.

Conversely, Bio-Techne Corporation, while smaller in scale, has exhibited impressive growth, with revenue increasing by over 200% during the same period. By 2023, Bio-Techne's revenue reached approximately $1.14 billion, reflecting its dynamic expansion in the biotech sector.

This comparison highlights the diverse strategies and market positions of these two companies, with Amgen maintaining its stronghold and Bio-Techne rapidly scaling its operations. The data for 2024 is incomplete, indicating potential for further analysis in the coming years.